Sirona Biochem Corp V.SBM

Results on Sedar

[Pandora]

Results have been posted on Sedar.

[pointer]

This post has been removed in accordance with Community Policy

[lscfa]

$105,000 revenue in Q4 = $80,000 USD = 10 kilos of 1067 to R+F.     On September 13, 2019, the Company entered into a manufacturing and supply agreement, pursuant to which the Company shall manufacture, test, label, package, store and supply R&F a minimum of 10 kilograms per year of skin lightening compound TFC-1067 for use in the United States, Canada, Australia and Japan

[word99]

The unknown is the maximum amount R + F needs going forward. 

[PutinKhuylo1]

Nothing earth shattering in the annual financials. Enough cash left to end of June, then subsequent events listed exercise of options on 2/21/21 for about $350,000, which should take us to November, unless there were some big ticket expenses in the interim. Revenue was minimal.

[pointer]

This post has been removed in accordance with Community Policy

[sakinny3]

hi Putin, the company burns more than 300,000 cad per month so the cash on hand at year end would have lasted till around end of Feb. The exercises added 1 more month to end March. So they need revenue now to keep going if they do not want to go back to the market with a PP. The Q4 revenue looks like the payment for 10kg of product, so we have our first visible returns. Much more to come clearly.

[sakinny3]

of course the other way to get hort term income is the share price goes up and all those options and warrants get exercised

[angel334]

Cash used in operating activities was -2.1 million CAD in FY 2020. So cash burn was less than 200 k CAD per month. Could now be higher as they build inventory. Depends on how R+F reimburses them.